organophosphonates has been researched along with quinacrine in 2 studies
| Studies (organophosphonates) | Trials (organophosphonates) | Recent Studies (post-2010) (organophosphonates) | Studies (quinacrine) | Trials (quinacrine) | Recent Studies (post-2010) (quinacrine) |
|---|---|---|---|---|---|
| 9,968 | 880 | 3,596 | 4,051 | 65 | 289 |
| Protein | Taxonomy | organophosphonates (IC50) | quinacrine (IC50) |
|---|---|---|---|
| cystic fibrosis transmembrane conductance regulator | Homo sapiens (human) | 19.88 | |
| Major prion protein | Mus musculus (house mouse) | 0.0951 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 2.896 | |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.964 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 1.983 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 4.5 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 4.5 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 4.5 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 4.5 | |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 3.736 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 2.28 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 4.5 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 1.489 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 1.825 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 3.857 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 1.255 | |
| Acetylcholinesterase | Homo sapiens (human) | 2.667 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.896 | |
| Histamine H2 receptor | Homo sapiens (human) | 3.535 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 2.065 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 2.663 | |
| D(3) dopamine receptor | Homo sapiens (human) | 1.318 | |
| Aldehyde oxidase 1 | Oryctolagus cuniculus (rabbit) | 10 | |
| Cholinesterase | Equus caballus (horse) | 4.5 | |
| Aldehyde oxidase | Homo sapiens (human) | 3.3 | |
| Cyclic GMP-AMP synthase | Homo sapiens (human) | 7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keister, DL; Raveed, NJ | 1 |
| Davies, JE; Jennings, SC; Ng, LL; Pettit, AI; Quinn, PA; Wong, RK | 1 |
2 other study(ies) available for organophosphonates and quinacrine
| Article | Year |
|---|---|
Energy-linked reactions in photosynthetic bacteria. IX. Pi-PPi exchange in Rhodospirillum rubrum.
Topics: Antimycin A; Bacterial Chromatophores; Chromatography, Ion Exchange; Chromatography, Thin Layer; Cyanides; Darkness; Diphosphates; Fluorides; Kinetics; Light; Magnesium; Oligomycins; Organophosphonates; Phenylhydrazines; Phosphates; Phosphorus Radioisotopes; Quinacrine; Rhodospirillum rubrum; Time Factors; Uncoupling Agents | 1974 |
Advanced glycation end products stimulate an enhanced neutrophil respiratory burst mediated through the activation of cytosolic phospholipase A2 and generation of arachidonic Acid.
Topics: Acetylcysteine; Adult; Arachidonic Acid; Arachidonic Acids; Cells, Cultured; Enzyme Inhibitors; Glycation End Products, Advanced; Group IV Phospholipases A2; Humans; Indomethacin; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Organophosphonates; Oxidation-Reduction; Phospholipases A; Phospholipases A2; Quinacrine; Reactive Oxygen Species; Respiratory Burst; Vascular Diseases | 2003 |